Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: Evidence from a clinical series
Mancia D, Buccino G, Scoditti U, Pini M, Taqliqfem AR. Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series. Ital J Neurol Sci 1999 20:231-5.
Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions
De Bmjin SF, Stam J, Koopman MM, Vendenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. BMJ 1998:316:589-92.
Durai sinus and cerebral venous thrombosis: Incidence in young women receiving oral contraceptives
Buchanan DS, Brazinsky JH. Durai sinus and cerebral venous thrombosis: incidence in young women receiving oral contraceptives. Arch Neurol 1970:22:440-4.
Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhoraocysteinemia in cerebral vein thrombosis. Blood 2003:102:1363-6.
Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhoraocysteinemia in cerebral vein thrombosis. Blood 2003:102:1363-6.
9
0032543748
High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and users of oral contraceptives
Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral vein thrombosis in carriers of a prothrombin gene mutation and users of oral contraceptives. N Engl J Med 1998:338:1793-7.